Table 1.
Baseline characteristics of participants.
| 6AA (n = 25) |
Placebo (n = 25) |
Difference (95% CI) |
p-Value | ||
|---|---|---|---|---|---|
| Age (years) | 49.8 ± 7.0 | 50.0 ± 5.1 | −0.1 (−3.4 to 3.6) |
0.9452 | |
| Sex (female/male) | 22/3 | 21/4 | - | 1.0000 | |
| Height (cm) | 158.6 ± 6.8 | 159.9 ± 6.3 | −1.3 (−2.4 to 5.0) |
0.4923 | |
| Body weight (kg) | 56.3 ± 9.2 | 58.0 ± 9.6 | −1.7 (−3.7 to 7.0) |
0.5339 | |
| BMI (kg/m2) | 22.3 ± 2.5 | 22.6 ± 2.8 | −0.3 (−1.2 to 1.8) |
0.6751 | |
| Body fat (%) | 30.2 ± 6.1 | 30.0 ± 6.1 | 0.2 (−3.7 to 3.3) |
0.9064 | |
| SMI (kg/m2) | 21.1 ± 3.4 | 22.0 ± 4.4 | −0.9 (−1.3 to 3.1) |
0.4078 | |
| K–L grade | 0 | 14 | 15 | - | 1.0000 |
| I | 11 | 10 | - | 1.0000 |
Data are represented as mean ± SD; CI, confidence interval; significance between groups was assessed by Student’s t-test for continuous variables and Fisher’s exact test for categorical variables.